Spread of hepatitis C virus among European injection drug users infected with HIV: a phylogenetic analysis.
about
Hepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and preventionHepatitis C virus prevalence and genetic diversity among pregnant women in Gabon, central AfricaNever injected, but hepatitis C virus-infected: a study among self-declared never-injecting drug users from the Amsterdam Cohort StudiesEmergence of Hepatitis C Virus Genotype 4: Phylogenetic Analysis Reveals Three Distinct Epidemiological ProfilesPredictors of sustained virological response to a 48-week course of pegylated interferon alfa-2a and ribavirin in patients infected with hepatitis C virus genotype 4Candidate hepatitis C vaccine trials and people who inject drugs: challenges and opportunitiesInactivation of HCV and HIV by microwave: a novel approach for prevention of virus transmission among people who inject drugsEligibility of persons who inject drugs for treatment of hepatitis C virus infection.Naturally occurring mutations in the nonstructural region 5B of hepatitis C virus (HCV) from treatment-naïve Korean patients chronically infected with HCV genotype 1b.Temporal changes in HCV genotype distribution in three different high risk populations in San Francisco, CaliforniaMolecular epidemiology of hepatitis C infection in Cyprus within the general population and high-risk cohorts.Phylogeography and epidemic history of hepatitis C virus genotype 4 in AfricaColonial history and contemporary transmission shape the genetic diversity of hepatitis C virus genotype 2 in Amsterdam.Phylogenetic clustering of hepatitis C virus among people who inject drugs in Vancouver, CanadaHepatitis C virus in healthy blood donors in Sri LankaThe impact of interleukin 28b gene polymorphism on the virological response to combined pegylated interferon and ribavirin therapy in chronic HCV genotype 4 infected egyptian patients using data mining analysisMolecular and contextual markers of hepatitis C virus and drug abuse.Cross sectional study of factors associated to self-reported blood-borne infections among drug users.Molecular methods of hepatitis C genotyping.Hepatitis C genotype 4: genotypic diversity, epidemiological profile, and clinical relevance of subtypes in Saudi Arabia.Significance of serum leptin and adiponectin levels in Egyptian patients with chronic hepatitis C virus associated hepatic steatosis and fibrosis.The full-length genome sequences of nine HCV genotype 4 variants representing a new subtype 4s and eight unclassified lineagesImproving outcome in patients with hepatitis C virus genotype 4.Current approaches to HCV infection in current and former injection drug users.Prevalence and correlates of hepatitis C infection among male injection drug users in detention, Tehran, Iran.Large scale screening of human sera for HCV RNA and GBV-C RNA.The epidemic dynamics of hepatitis C virus subtypes 4a and 4d in Saudi ArabiaHepatitis C virus infection in the Middle East and North Africa "MENA" region: injecting drug users (IDUs) is an under-investigated population.Mixed HCV infection and reinfection in people who inject drugs--impact on therapy.Direct-acting antiviral agents for HCV infection affecting people who inject drugs.Hepatitis C virus subtypes circulating among intravenous drug users in Lisbon, Portugal.Prevalence and distribution of hepatitis C virus genotypes in Spain during the 2000-2015 period (the GEHEP 005 study).Hepatitis C virus genotype 3A in a population of injecting drug users in Montenegro: Bayesian and evolutionary analysis.Epidemiological characteristics and response to peginterferon plus ribavirin treatment of hepatitis C virus genotype 4 infection.Screening for hepatitis B and C in first-generation Egyptian migrants living in the Netherlands.Coinfection with HIV and hepatitis C virus among injection drug users in southern China.Usefulness of Dried Blood Spots (DBS) to perform hepatitis C virus genotyping in drug users in Senegal.Recommendations for the management of hepatitis C virus infection among people who inject drugs.Epidemic dispersion of HIV and HCV in a population of co-infected Romanian injecting drug users.Hepatitis C virus genotype 4 in Southern and Central Spain does not originate from recent foreign migration waves.
P2860
Q27014761-BAD22F9F-191E-40E9-9C1E-6E4BBC7F9C81Q27486393-F9A33500-BF00-45A6-B930-511A9ABD903AQ27489900-5D82ABE7-9941-41CE-89DD-56BA7E884A6FQ27490460-563F71A3-368A-4729-B71C-811CE800EF04Q27490866-EE19C6C2-AAAB-4332-80E3-3D9441F9AE81Q30226978-15863329-C97C-4BC6-9240-02FE539518A7Q30369227-F341CF63-41D1-4932-B420-055C0FE2DDE5Q30429470-61B15DE3-665E-41D9-AF2A-2EA408E1B069Q31149778-F49F6EDB-2A62-4396-B177-6677D4DCE342Q33978978-7543D623-DFC1-41DF-863A-CF0B01054070Q34063019-8DBF4A8C-4FB3-458F-87FD-4B4877DC56A5Q34172845-CA9C6173-AFA7-40B0-A815-F2FA759E6033Q34264303-EF197009-4351-4B1C-BD92-908CEBE6BC55Q34415820-68AE1A06-F470-47B5-A16D-7A664426E8AEQ34862674-0568E1B8-3DCC-467C-8C13-016952A1458FQ34996891-479E79BE-C799-4B38-BB52-CE5CFA0013B8Q35660841-2B8F7136-75F4-4586-AC66-25419EE0FA5BQ35841089-4D2416EB-999C-401F-AEA5-0B856F2BBE0DQ36192689-D530526F-1233-49A9-ABE9-6DCBC50666F0Q36702487-833F66E7-F9E4-4D5C-9711-9A5F81126C90Q36812856-819B3A10-3648-40ED-AECE-257822EECC8FQ36880945-A46FDD0B-8EBF-4818-AA4F-7B27C1F47849Q36953707-C53C5267-D2FE-4B53-9B4C-DE1AC0F267E6Q37235530-223EFA8C-9768-4776-8E49-5BEAC9BCCC5FQ37470458-5AAB0D1E-934C-48AF-84F3-1A3D01FF707AQ37626109-DBFEA38C-C22F-4999-A744-AA32BF257041Q37712968-78974348-6E37-41B5-918C-91EC7254E309Q37975114-C6AE2E23-DEAD-4B9A-914F-FCE92F4EF570Q38381584-651E106E-2608-4FB1-BB15-8B98D4C9E1BEQ38613271-4A3C6848-1D9E-4394-8313-F15BC0C36E7EQ38929061-9174161D-321B-4785-9EFC-D70AE539535FQ38935930-2CCFF761-FD71-4C8D-BE40-6C4C5E65C0EBQ38962986-80D44B40-9712-4919-8B5A-2B53183DB1AFQ39411402-9965061D-F8DC-4646-B628-15851ABB3933Q39634561-9D5A17FD-4BF4-46D3-B48C-E817A72E610AQ40375524-BCDC1A55-8281-492C-B19A-FCA612DC78EDQ40857029-306014AE-9EDF-49E4-A93E-C9405C49B183Q41047662-45023798-F808-4146-BCDE-07F90FA71AE4Q41920886-35EDE56C-75A0-45B5-BEC4-542996BFB99AQ42254820-EEFA4381-BC0C-4E4F-892F-24C28CBA55EF
P2860
Spread of hepatitis C virus among European injection drug users infected with HIV: a phylogenetic analysis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Spread of hepatitis C virus am ...... HIV: a phylogenetic analysis.
@en
Spread of hepatitis C virus am ...... HIV: a phylogenetic analysis.
@nl
type
label
Spread of hepatitis C virus am ...... HIV: a phylogenetic analysis.
@en
Spread of hepatitis C virus am ...... HIV: a phylogenetic analysis.
@nl
prefLabel
Spread of hepatitis C virus am ...... HIV: a phylogenetic analysis.
@en
Spread of hepatitis C virus am ...... HIV: a phylogenetic analysis.
@nl
P2093
P50
P356
P1476
Spread of hepatitis C virus am ...... h HIV: a phylogenetic analysis
@en
P2093
Alexandra Cochrane
Barbara Broers
European and Italian Seroconverter Studies
Faroudy Boufassa
Giovanni Rezza
Inge Verhaest
J Roy Robertson
Raymond P Brettle
Robert Zangerle
Roel A Coutinho
P304
P356
10.1086/380821
P407
P577
2004-01-08T00:00:00Z